0001836833FALSE2025Q3--01-310.2xbrli:sharesiso4217:USDiso4217:USDxbrli:sharespl:segmentxbrli:pureutr:Ypl:providerpl:tranchepl:tradingDay00018368332024-02-012024-10-310001836833us-gaap:CommonClassAMember2024-02-012024-10-310001836833us-gaap:WarrantMember2024-02-012024-10-310001836833us-gaap:CommonClassAMember2024-12-030001836833us-gaap:CommonClassBMember2024-12-0300018368332024-10-3100018368332024-01-310001836833us-gaap:CommonClassAMember2024-10-310001836833us-gaap:CommonClassAMember2024-01-310001836833us-gaap:CommonClassBMember2024-10-310001836833us-gaap:CommonClassBMember2024-01-310001836833us-gaap:CommonClassCMember2024-10-310001836833us-gaap:CommonClassCMember2024-01-3100018368332024-08-012024-10-3100018368332023-08-012023-10-3100018368332023-02-012023-10-310001836833us-gaap:CommonStockMember2023-01-310001836833us-gaap:AdditionalPaidInCapitalMember2023-01-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-310001836833us-gaap:RetainedEarningsMember2023-01-3100018368332023-01-310001836833us-gaap:CommonStockMember2023-02-012023-04-300001836833us-gaap:AdditionalPaidInCapitalMember2023-02-012023-04-3000018368332023-02-012023-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-02-012023-04-300001836833us-gaap:RetainedEarningsMember2023-02-012023-04-300001836833us-gaap:CommonStockMember2023-04-300001836833us-gaap:AdditionalPaidInCapitalMember2023-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-300001836833us-gaap:RetainedEarningsMember2023-04-3000018368332023-04-300001836833us-gaap:CommonStockMember2023-05-012023-07-310001836833us-gaap:AdditionalPaidInCapitalMember2023-05-012023-07-3100018368332023-05-012023-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-05-012023-07-310001836833us-gaap:RetainedEarningsMember2023-05-012023-07-310001836833us-gaap:CommonStockMember2023-07-310001836833us-gaap:AdditionalPaidInCapitalMember2023-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-310001836833us-gaap:RetainedEarningsMember2023-07-3100018368332023-07-310001836833us-gaap:CommonStockMember2023-08-012023-10-310001836833us-gaap:AdditionalPaidInCapitalMember2023-08-012023-10-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-08-012023-10-310001836833us-gaap:RetainedEarningsMember2023-08-012023-10-310001836833us-gaap:CommonStockMember2023-10-310001836833us-gaap:AdditionalPaidInCapitalMember2023-10-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-310001836833us-gaap:RetainedEarningsMember2023-10-3100018368332023-10-310001836833us-gaap:CommonStockMember2024-01-310001836833us-gaap:AdditionalPaidInCapitalMember2024-01-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-310001836833us-gaap:RetainedEarningsMember2024-01-310001836833us-gaap:CommonStockMember2024-02-012024-04-300001836833us-gaap:AdditionalPaidInCapitalMember2024-02-012024-04-3000018368332024-02-012024-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-02-012024-04-300001836833us-gaap:RetainedEarningsMember2024-02-012024-04-300001836833us-gaap:CommonStockMember2024-04-300001836833us-gaap:AdditionalPaidInCapitalMember2024-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-300001836833us-gaap:RetainedEarningsMember2024-04-3000018368332024-04-300001836833us-gaap:CommonStockMember2024-05-012024-07-310001836833us-gaap:AdditionalPaidInCapitalMember2024-05-012024-07-3100018368332024-05-012024-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-05-012024-07-310001836833us-gaap:RetainedEarningsMember2024-05-012024-07-310001836833us-gaap:CommonStockMember2024-07-310001836833us-gaap:AdditionalPaidInCapitalMember2024-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-310001836833us-gaap:RetainedEarningsMember2024-07-3100018368332024-07-310001836833us-gaap:CommonStockMember2024-08-012024-10-310001836833us-gaap:AdditionalPaidInCapitalMember2024-08-012024-10-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-08-012024-10-310001836833us-gaap:RetainedEarningsMember2024-08-012024-10-310001836833us-gaap:CommonStockMember2024-10-310001836833us-gaap:AdditionalPaidInCapitalMember2024-10-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-310001836833us-gaap:RetainedEarningsMember2024-10-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-02-012024-10-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2024-02-012024-10-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2024-08-012024-10-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-08-012023-10-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-02-012023-10-3100018368332024-11-012024-10-310001836833country:US2024-08-012024-10-310001836833country:US2023-08-012023-10-310001836833country:US2024-02-012024-10-310001836833country:US2023-02-012023-10-310001836833us-gaap:NonUsMember2024-08-012024-10-310001836833us-gaap:NonUsMember2023-08-012023-10-310001836833us-gaap:NonUsMember2024-02-012024-10-310001836833us-gaap:NonUsMember2023-02-012023-10-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-10-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-10-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-10-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-10-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-10-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-10-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:MeasurementInputPriceVolatilityMember2024-10-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:MeasurementInputPriceVolatilityMember2024-01-310001836833pl:SaloSciencesMemberus-gaap:MeasurementInputExpectedTermMember2024-10-310001836833pl:WarrantsPrivatePlacementMember2023-01-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-01-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-01-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-01-310001836833pl:WarrantsPrivatePlacementMember2023-02-012023-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-02-012023-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-02-012023-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-02-012023-04-300001836833pl:WarrantsPrivatePlacementMember2023-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-04-300001836833pl:WarrantsPrivatePlacementMember2023-05-012023-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-05-012023-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-05-012023-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-05-012023-07-310001836833pl:WarrantsPrivatePlacementMember2023-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-07-310001836833pl:WarrantsPrivatePlacementMember2023-08-012023-10-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-08-012023-10-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-08-012023-10-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-08-012023-10-310001836833pl:WarrantsPrivatePlacementMember2023-10-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-10-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-10-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-10-310001836833pl:WarrantsPrivatePlacementMember2024-01-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-01-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-01-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-01-310001836833pl:WarrantsPrivatePlacementMember2024-02-012024-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-02-012024-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-02-012024-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-02-012024-04-300001836833pl:WarrantsPrivatePlacementMember2024-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-04-300001836833pl:WarrantsPrivatePlacementMember2024-05-012024-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-05-012024-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-05-012024-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-05-012024-07-310001836833pl:WarrantsPrivatePlacementMember2024-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-07-310001836833pl:WarrantsPrivatePlacementMember2024-08-012024-10-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-08-012024-10-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-08-012024-10-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-08-012024-10-310001836833pl:WarrantsPrivatePlacementMember2024-10-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-10-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-10-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-10-310001836833pl:CustomerConsentEscrowMemberpl:SinergiseMember2024-08-012024-10-310001836833pl:SinergiseMember2023-08-042023-08-040001836833pl:SinergiseMember2024-04-012024-04-300001836833pl:IndemnityEscrowMemberpl:SinergiseMember2023-08-042023-08-040001836833pl:CustomerConsentEscrowMemberpl:SinergiseMember2023-08-042023-08-040001836833pl:SinergiseMemberpl:CustomerConsentEscrowContingentConsiderationMember2023-08-042023-08-040001836833pl:SinergiseMember2023-08-040001836833pl:SinergiseMemberus-gaap:DevelopedTechnologyRightsMember2023-08-040001836833pl:SinergiseMemberus-gaap:CustomerRelationshipsMember2023-08-040001836833pl:SinergiseMemberus-gaap:OtherIntangibleAssetsMember2023-08-040001836833pl:SinergiseMember2024-08-012024-10-310001836833pl:SinergiseMember2024-02-012024-10-310001836833pl:SinergiseMember2023-08-042023-10-310001836833pl:SinergiseMemberpl:CostOfRevenueMember2023-02-012023-10-310001836833pl:SinergiseMemberpl:CostOfRevenueMember2023-08-012023-10-310001836833pl:SinergiseMemberus-gaap:ResearchAndDevelopmentExpenseMember2023-02-012023-10-310001836833pl:SinergiseMemberus-gaap:ResearchAndDevelopmentExpenseMember2023-08-012023-10-310001836833pl:SinergiseMemberus-gaap:SellingAndMarketingExpenseMember2023-08-012023-10-310001836833pl:SinergiseMemberus-gaap:SellingAndMarketingExpenseMember2023-02-012023-10-310001836833pl:SinergiseMemberus-gaap:GeneralAndAdministrativeExpenseMember2023-02-012023-10-310001836833pl:SinergiseMemberus-gaap:GeneralAndAdministrativeExpenseMember2023-08-012023-10-310001836833pl:SinergiseMember2023-02-012023-10-310001836833pl:SinergiseMember2023-08-012023-10-310001836833pl:SinergiseMember2024-10-310001836833us-gaap:MoneyMarketFundsMember2024-10-310001836833pl:SinergiseMember2024-01-310001836833us-gaap:MoneyMarketFundsMember2024-01-310001836833us-gaap:USTreasurySecuritiesMember2024-10-310001836833us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-10-310001836833us-gaap:CorporateBondSecuritiesMember2024-10-310001836833us-gaap:CertificatesOfDepositMember2024-10-310001836833us-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:CertificatesOfDepositMember2024-01-310001836833pl:SatellitesMember2024-10-310001836833pl:SatellitesMember2024-01-310001836833pl:SatellitesInProcessAndNotPlacedIntoServiceMember2024-10-310001836833pl:SatellitesInProcessAndNotPlacedIntoServiceMember2024-01-310001836833us-gaap:LeaseholdImprovementsMember2024-10-310001836833us-gaap:LeaseholdImprovementsMember2024-01-310001836833pl:GroundStationAndGroundStationEquipmentMember2024-10-310001836833pl:GroundStationAndGroundStationEquipmentMember2024-01-310001836833us-gaap:FurnitureAndFixturesMember2024-10-310001836833us-gaap:FurnitureAndFixturesMember2024-01-310001836833pl:ComputerEquipmentAndSoftwareMember2024-10-310001836833pl:ComputerEquipmentAndSoftwareMember2024-01-310001836833country:US2024-10-310001836833country:US2024-01-310001836833us-gaap:NonUsMember2024-10-310001836833us-gaap:NonUsMember2024-01-310001836833pl:SatellitesMember2024-08-012024-10-310001836833pl:SatellitesMember2024-02-012024-10-310001836833pl:SatellitesMember2023-08-012023-10-310001836833pl:SatellitesMember2023-02-012023-10-310001836833us-gaap:DevelopedTechnologyRightsMember2024-10-310001836833us-gaap:DevelopedTechnologyRightsMember2024-02-012024-10-310001836833us-gaap:DevelopedTechnologyRightsMember2024-01-310001836833us-gaap:DevelopedTechnologyRightsMember2023-02-012024-01-310001836833us-gaap:AcquiredFilmLibrariesMember2024-10-310001836833us-gaap:AcquiredFilmLibrariesMember2024-02-012024-10-310001836833us-gaap:AcquiredFilmLibrariesMember2024-01-310001836833us-gaap:AcquiredFilmLibrariesMember2023-02-012024-01-310001836833us-gaap:CustomerRelationshipsMember2024-10-310001836833us-gaap:CustomerRelationshipsMember2024-02-012024-10-310001836833us-gaap:CustomerRelationshipsMember2024-01-310001836833us-gaap:CustomerRelationshipsMember2023-02-012024-01-310001836833us-gaap:TrademarksAndTradeNamesMember2024-10-310001836833us-gaap:TrademarksAndTradeNamesMember2024-02-012024-10-310001836833us-gaap:TrademarksAndTradeNamesMember2024-01-310001836833us-gaap:TrademarksAndTradeNamesMember2023-02-012024-01-3100018368332023-02-012024-01-3100018368332024-04-012024-04-3000018368332024-06-012024-06-300001836833us-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMember2024-08-012024-10-310001836833us-gaap:CostOfSalesMemberpl:StockBasedCompensationMember2024-08-012024-10-310001836833us-gaap:CostOfSalesMember2024-08-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:EmployeeSeveranceMember2024-08-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberpl:StockBasedCompensationMember2024-08-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2024-08-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMemberus-gaap:EmployeeSeveranceMember2024-08-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMemberpl:StockBasedCompensationMember2024-08-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMember2024-08-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberus-gaap:EmployeeSeveranceMember2024-08-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberpl:StockBasedCompensationMember2024-08-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2024-08-012024-10-310001836833us-gaap:EmployeeSeveranceMember2024-08-012024-10-310001836833pl:StockBasedCompensationMember2024-08-012024-10-310001836833us-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMember2024-02-012024-10-310001836833us-gaap:CostOfSalesMemberpl:StockBasedCompensationMember2024-02-012024-10-310001836833us-gaap:CostOfSalesMember2024-02-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:EmployeeSeveranceMember2024-02-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberpl:StockBasedCompensationMember2024-02-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2024-02-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMemberus-gaap:EmployeeSeveranceMember2024-02-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMemberpl:StockBasedCompensationMember2024-02-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMember2024-02-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberus-gaap:EmployeeSeveranceMember2024-02-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberpl:StockBasedCompensationMember2024-02-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2024-02-012024-10-310001836833us-gaap:EmployeeSeveranceMember2024-02-012024-10-310001836833pl:StockBasedCompensationMember2024-02-012024-10-310001836833pl:HeadcountReduction2024Member2023-02-012023-10-310001836833pl:HeadcountReduction2024Member2023-08-012023-10-3100018368332023-08-012023-08-310001836833us-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMember2023-08-012023-10-310001836833us-gaap:CostOfSalesMemberpl:StockBasedCompensationMember2023-08-012023-10-310001836833us-gaap:CostOfSalesMember2023-08-012023-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:EmployeeSeveranceMember2023-08-012023-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberpl:StockBasedCompensationMember2023-08-012023-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2023-08-012023-10-310001836833us-gaap:SellingAndMarketingExpenseMemberus-gaap:EmployeeSeveranceMember2023-08-012023-10-310001836833us-gaap:SellingAndMarketingExpenseMemberpl:StockBasedCompensationMember2023-08-012023-10-310001836833us-gaap:SellingAndMarketingExpenseMember2023-08-012023-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberus-gaap:EmployeeSeveranceMember2023-08-012023-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberpl:StockBasedCompensationMember2023-08-012023-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2023-08-012023-10-310001836833us-gaap:EmployeeSeveranceMember2023-08-012023-10-310001836833pl:StockBasedCompensationMember2023-08-012023-10-310001836833pl:HeadcountReduction2023Member2024-08-012024-10-310001836833pl:HeadcountReduction2023Member2024-02-012024-10-310001836833pl:RDServicesAgreementMember2020-12-310001836833pl:RDServicesAgreementMember2024-08-012024-10-310001836833pl:RDServicesAgreementMember2024-02-012024-10-310001836833pl:RDServicesAgreementMember2023-08-012023-10-310001836833pl:RDServicesAgreementMember2023-02-012023-10-310001836833pl:RDServicesAgreementMember2023-02-012024-01-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2022-08-012022-08-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2024-08-012024-10-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2024-02-012024-10-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-08-012023-10-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-02-012023-10-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-02-012024-01-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-07-012023-07-310001836833pl:DMYIVLLCMember2021-03-092021-03-090001836833us-gaap:CommonClassAMemberpl:DMYIVLLCMember2021-03-090001836833pl:RedeemableWarrantMemberpl:DMYIVLLCMember2021-03-090001836833pl:WarrantsPublicMemberus-gaap:CommonClassAMember2021-03-090001836833pl:WarrantsPrivatePlacementMemberpl:DMYIVLLCMember2021-03-090001836833pl:WarrantsPrivatePlacementMember2021-12-0700018368332021-12-070001836833pl:DerivativeInstrumentPeriod1Member2021-12-070001836833pl:DerivativeInstrumentPeriod2Member2021-12-070001836833pl:DerivativeInstrumentPeriod3Member2021-12-070001836833pl:DerivativeInstrumentPeriod4Member2021-12-0700018368332021-12-072021-12-070001836833pl:WarrantsPublicMember2024-01-310001836833pl:WarrantsPublicMember2024-10-310001836833pl:WarrantsPrivatePlacementVestingMember2024-10-310001836833pl:WarrantsPrivatePlacementVestingMember2024-01-310001836833pl:A2020ConvertibleNotesMemberus-gaap:SeriesDPreferredStockMember2024-10-310001836833pl:A2020ConvertibleNotesMemberus-gaap:SeriesDPreferredStockMember2024-01-310001836833pl:A2020ConvertibleNotesMemberus-gaap:ConvertibleDebtMemberus-gaap:SeriesDPreferredStockMember2024-10-310001836833pl:A2020ConvertibleNotesMemberus-gaap:ConvertibleDebtMemberus-gaap:SeriesDPreferredStockMember2024-01-310001836833pl:A2020ConvertibleNotesMember2024-10-310001836833pl:PlanetLabsPBCMemberpl:GoogleMemberus-gaap:CommonClassAMember2024-10-310001836833pl:PlanetLabsPBCMemberpl:GoogleMemberus-gaap:CommonClassAMember2024-01-310001836833pl:PlanetLabsPBCMemberpl:GoogleMember2024-01-310001836833pl:PlanetLabsPBCMemberpl:GoogleMember2024-10-310001836833us-gaap:RelatedPartyMember2017-04-012017-04-300001836833us-gaap:RelatedPartyMember2022-04-012022-04-300001836833us-gaap:RelatedPartyMemberpl:ContentLicensingMember2023-02-012023-10-310001836833us-gaap:RelatedPartyMember2023-07-012023-07-310001836833us-gaap:RelatedPartyMember2023-07-310001836833us-gaap:RelatedPartyMembersrt:MaximumMember2023-07-310001836833us-gaap:RelatedPartyMember2024-08-310001836833us-gaap:RelatedPartyMember2024-02-012024-10-310001836833us-gaap:RelatedPartyMember2024-08-012024-10-310001836833us-gaap:RelatedPartyMember2023-08-012023-10-310001836833us-gaap:RelatedPartyMember2023-02-012023-10-310001836833pl:GoogleMember2024-10-310001836833pl:GoogleMember2024-01-310001836833us-gaap:RelatedPartyMemberpl:HostingAndOtherServicesMember2024-08-012024-10-310001836833us-gaap:RelatedPartyMemberpl:HostingAndOtherServicesMember2024-02-012024-10-310001836833us-gaap:RelatedPartyMemberpl:HostingAndOtherServicesMember2023-08-012023-10-310001836833us-gaap:RelatedPartyMemberpl:HostingAndOtherServicesMember2023-02-012023-10-310001836833us-gaap:RelatedPartyMember2021-06-280001836833us-gaap:CostOfSalesMember2023-02-012023-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2023-02-012023-10-310001836833us-gaap:SellingAndMarketingExpenseMember2023-02-012023-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2023-02-012023-10-310001836833us-gaap:EmployeeStockOptionMember2024-10-310001836833us-gaap:EmployeeStockOptionMember2024-02-012024-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-01-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-02-012024-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-08-012024-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2023-08-012023-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2023-02-012023-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-02-012024-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMembersrt:MinimumMember2024-02-012024-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMembersrt:MaximumMember2024-02-012024-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-08-012024-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2023-08-012023-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2023-02-012023-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-10-310001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-04-012024-04-300001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-08-012024-10-310001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-02-012024-10-310001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-10-310001836833pl:EarnOutSharesMember2024-08-012024-10-310001836833pl:EarnOutSharesMember2024-02-012024-10-310001836833pl:EarnOutSharesMember2024-10-310001836833pl:EarnOutSharesMember2023-08-012023-10-310001836833pl:EarnOutSharesMember2023-02-012023-10-310001836833pl:VanderSatBVMemberus-gaap:StockCompensationPlanMemberus-gaap:CommonClassAMember2021-12-132021-12-130001836833pl:VanderSatBVMember2021-12-132021-12-130001836833pl:VanderSatBVMember2023-08-012023-10-310001836833pl:VanderSatBVMember2023-02-012023-10-310001836833pl:WarrantsClassACommonStockMember2024-02-012024-10-310001836833pl:WarrantsClassACommonStockMember2023-02-012023-10-310001836833us-gaap:EmployeeStockOptionMember2024-02-012024-10-310001836833us-gaap:EmployeeStockOptionMember2023-02-012023-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-02-012024-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2023-02-012023-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-02-012024-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2023-02-012023-10-310001836833us-gaap:EmployeeStockMember2024-02-012024-10-310001836833us-gaap:EmployeeStockMember2023-02-012023-10-310001836833pl:EarnOutSharesMember2024-02-012024-10-310001836833pl:EarnOutSharesMember2023-02-012023-10-310001836833pl:SponsorEarnOutSharesMember2024-02-012024-10-310001836833pl:SponsorEarnOutSharesMember2023-02-012023-10-310001836833pl:WarrantsPublicMember2024-02-012024-10-310001836833pl:WarrantsPublicMember2023-02-012023-10-310001836833pl:WarrantsPrivatePlacementMember2024-02-012024-10-310001836833pl:WarrantsPrivatePlacementMember2023-02-012023-10-310001836833pl:StockOptionsEarlyExercisedSubjectToFutureVestingMember2024-02-012024-10-310001836833pl:StockOptionsEarlyExercisedSubjectToFutureVestingMember2023-02-012023-10-310001836833pl:SharesIssuedInAcquisitionSubjectToFutureVestingMember2024-02-012024-10-310001836833pl:SharesIssuedInAcquisitionSubjectToFutureVestingMember2023-02-012023-10-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended October 31, 2024
OR
| | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _______________ to _______________.
Commission file number 001-40166
Planet Labs PBC
(Exact name of registrant as specified in its charter)
| | | | | | | | | | | |
Delaware | | 85-4299396 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| |
645 Harrison Street, Floor 4, San Francisco, California | | | 94107 |
(Address of principal executive offices) | | (Zip Code) |
(415) 829-3313
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Class A common stock, par value $0.0001 per share | PL | New York Stock Exchange |
Warrants to purchase Class A common stock, at an exercise price of $11.50 per share | PL WS | New York Stock Exchange |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
| | | | | | | | | | | |
Large accelerated filer | ☒ | Accelerated filer | ☐ |
Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
The registrant had 275,551,243 outstanding shares of Class A common stock, and 21,157,586 outstanding shares of Class B common stock, as of December 3, 2024.
TABLE OF CONTENTS
| | | | | | | | |
| | Page |
| | |
Item 1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Item 2. | | |
Item 3. | | |
Item 4. | | |
| | |
| | |
| | |
Item 1. | | |
Item 1A. | | |
Item 2. | | |
Item 3. | | |
Item 4. | | |
Item 5. | | |
Item 6. | | |
| | |
| |
| | |
| | |
| | |
| | |
| | |
Unless the context otherwise requires, the “Company”, “Planet”, “we”, “our”, “us” and similar terms refer to Planet Labs PBC, a Delaware public benefit corporation (f/k/a dMY Technology Group, Inc. IV, a Delaware corporation), and its consolidated subsidiaries.
Cautionary Note Regarding Forward Looking Information
This Quarterly Report on Form 10-Q for the quarter ended October 31, 2024 (the “Form 10-Q” or “this report”) includes statements that express Planet’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements.” Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “seek,” “may,” “will,” “could,” “can,” “should,” “would,” “believes,” “predicts,” “potential,” “strategy,” “opportunity,” “aim,” “continue,” and similar expressions or the negative thereof, or discussions of strategy, plans, objectives, intentions, estimates, forecasts, outlook, assumptions, or goals, are intended to identify such forward-looking statements. Forward-looking statements appear in a number of places throughout this report and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the markets in which Planet operates. Factors that may impact such forward-looking statements include:
•our future financial performance, including expectations regarding our revenue, cost of revenue, operating expenses, capital expenditures, cash flows and our ability to achieve profitability;
•our ability to attract and retain customers, including our ability to renew existing contracts and expand our relationships with existing customers;
•our expectations regarding the value of our offerings to our customers over time;
•our expectations regarding market growth, including our ability to grow in existing markets and expand into new markets;
•our ability to continue to improve our data and offer software and analytic solutions to improve the value of our data;
•our ability to continue to invest in our sales and marketing, software platform development, machine learning and analytic tools as well as our applications and new satellite technologies;
•our relationships with third-party partners, vendors and solution providers;
•our ability to manage risks and challenges associated with our financial condition and results of operations;
•our expectations regarding the future impact of seasonality on our business;
•our management of future growth and business operations, as well as the expected results of our workforce reduction;
•our expectations regarding the realization of our U.S. and foreign deferred tax assets;
•our ability to maintain, protect and enhance our intellectual property; and
•the increased expenses associated with being a public company.
The foregoing list may not contain all of the forward-looking statements made in this Form 10-Q. Such forward-looking statements are based on available current market material and our current expectations, beliefs and forecasts concerning future events and their potential effects on Planet. The outcome of the events described in these forward-looking statements is subject to known and unknown risks, uncertainties, and other factors, including those described in the “Risk Factors” section of our most recent Annual Report on Form 10-K, this Form 10-Q, as well as the other documents filed by us from time to time with the U.S. Securities and Exchange Commission (“SEC”). We operate in a rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Form 10-Q. We cannot assure you that the results, events, and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.
The forward-looking statements contained in this Form 10-Q are based on information available to us at the time of filing of this Form 10-Q and relate only to events as of the date on which the statements are made. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
Part I. - Financial Information
Item 1. Financial Statements.
Planet Labs PBC
Condensed Consolidated Balance Sheets (Unaudited)
| | | | | | | | | | | |
| |
(in thousands, except share and par value amounts) | October 31, 2024 | | January 31, 2024 |
Assets | | | |
Current assets | | | |
Cash and cash equivalents | $ | 138,969 | | | $ | 83,866 | |
Restricted cash and cash equivalents, current | 6,525 | | 8,360 |
Short-term investments | 103,255 | | 215,041 |
Accounts receivable, net of allowance of $446 and $1,539, respectively | 38,853 | | 43,320 |
Prepaid expenses and other current assets | 13,992 | | 19,564 |
Total current assets | 301,594 | | 370,151 |
Property and equipment, net | 116,920 | | 113,429 |
Capitalized internal-use software, net | 18,259 | | 14,973 |
Goodwill | 137,411 | | 136,256 |
Intangible assets, net | 29,231 | | 32,448 |
Restricted cash and cash equivalents, non-current | 4,437 | | 9,972 |
Operating lease right-of-use assets | 20,829 | | 22,339 |
Other non-current assets | 2,083 | | 2,429 |
Total assets | $ | 630,764 | | | $ | 701,997 | |
Liabilities and Stockholders’ Equity | | | |
Current liabilities | | | |
Accounts payable | $ | 3,572 | | | $ | 2,601 | |
Accrued and other current liabilities | 43,670 | | 44,779 |
Deferred revenue | 66,462 | | 72,327 |
Liability from early exercise of stock options | 6,275 | | 8,964 |
Operating lease liabilities, current | 9,105 | | 7,978 |
Total current liabilities | 129,084 | | 136,649 |
Deferred revenue | 11,230 | | 5,293 |
Deferred hosting costs | 6,665 | | 7,101 |
Public and private placement warrant liabilities | 1,835 | | 2,961 |
Operating lease liabilities, non-current | 13,819 | | 16,952 |
Contingent consideration | 2,871 | | 5,885 |
Other non-current liabilities | 655 | | 9,138 |
Total liabilities | 166,159 | | 183,979 |
Commitments and contingencies (Note 10) | | | |
Stockholders’ equity | | | |
Common stock, $0.0001 par value, 570,000,000, 30,000,000 and 30,000,000 Class A, Class B and Class C shares authorized at October 31, 2024 and January 31, 2024, 275,274,858 and 268,117,905 Class A shares issued and outstanding at October 31, 2024 and January 31, 2024, respectively, 21,157,586 Class B shares issued and outstanding at October 31, 2024 and January 31, 2024, 0 Class C shares issued and outstanding at October 31, 2024 and January 31, 2024 | 28 | | 28 |
Additional paid-in capital | 1,631,077 | | 1,596,201 |
Accumulated other comprehensive income | 1,347 | | 1,594 |
Accumulated deficit | (1,167,847) | | (1,079,805) |
Total stockholders’ equity | 464,605 | | 518,018 |
Total liabilities and stockholders’ equity | $ | 630,764 | | | $ | 701,997 | |
See accompanying notes to unaudited condensed consolidated financial statements.
Planet Labs PBC
Condensed Consolidated Statements of Operations (Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended October 31, | | Nine Months Ended October 31, |
(in thousands, except share and per share amounts) | 2024 | | 2023 | | 2024 | | 2023 |
Revenue | $ | 61,266 | | | $ | 55,380 | | | $ | 182,798 | | | $ | 161,844 | |
Cost of revenue | 23,749 | | | 29,350 | | | 81,288 | | | 81,375 | |
Gross profit | 37,517 | | | 26,030 | | | 101,510 | | | 80,469 | |
Operating expenses | | | | | | | |
Research and development | 25,216 | | | 33,002 | | | 78,055 | | | 87,929 | |
Sales and marketing | 16,795 | | | 20,774 | | | 62,013 | | | 66,209 | |
General and administrative | 18,114 | | | 20,112 | | | 58,198 | | | 62,161 | |
Total operating expenses | 60,125 | | | 73,888 | | | 198,266 | | 216,299 | |
Loss from operations | (22,608) | | | (47,858) | | | (96,756) | | | (135,830) | |
Interest income | 2,414 | | | 3,445 | | | 8,292 | | | 11,753 | |
Change in fair value of warrant liabilities | 198 | | | 6,833 | | | 1,126 | | | 14,004 | |
Other income (expense), net | (60) | | | (69) | | | 660 | | | 894 | |
Total other income, net | 2,552 | | | 10,209 | | | 10,078 | | | 26,651 | |
Loss before provision for income taxes | (20,056) | | | (37,649) | | | (86,678) | | | (109,179) | |
Provision for income taxes | 25 | | | 355 | | | 1,364 | | | 1,244 | |
Net loss | $ | (20,081) | | | $ | (38,004) | | | $ | (88,042) | | | $ | (110,423) | |
Basic and diluted net loss per share attributable to common stockholders | $ | (0.07) | | | $ | (0.13) | | | $ | (0.30) | | | $ | (0.40) | |
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders | 293,338,324 | | 284,197,733 | | 290,674,554 | | 277,252,951 |
See accompanying notes to unaudited condensed consolidated financial statements.
Planet Labs PBC
Condensed Consolidated Statements of Comprehensive Loss (Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended October 31, | | Nine Months Ended October 31, |
(in thousands) | 2024 | | 2023 | | 2024 | | 2023 |
Net loss | $ | (20,081) | | | $ | (38,004) | | | $ | (88,042) | | | $ | (110,423) | |
Other comprehensive income (loss), net of tax: | | | | | | | |
Foreign currency translation adjustment | 52 | | | (1,667) | | | (159) | | | (1,543) | |
Change in fair value of available-for-sale securities | 48 | | | 89 | | | (88) | | | (970) | |
Other comprehensive income (loss), net of tax | 100 | | | (1,578) | | | (247) | | | (2,513) | |
Comprehensive loss | $ | (19,981) | | | $ | (39,582) | | | $ | (88,289) | | | $ | (112,936) | |
See accompanying notes to unaudited condensed consolidated financial statements.
Planet Labs PBC
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(in thousands, except share amounts) | | Common Stock | | Additional Paid-in Capital | | Accumulated Other Comprehensive Income (Loss) | | Accumulated Deficit | | Total Stockholders’ Equity |
| Shares | | Amount |
Balances at January 31, 2023 | | 271,783,561 | | $ | 27 | | | $ | 1,513,102 | | | $ | 2,271 | | | $ | (939,296) | | | $ | 576,104 | |
Issuance of Class A common stock from the exercise of common stock options | | 1,018,385 | | — | | 3,295 | | — | | — | | 3,295 |
Issuance of Class A common stock upon vesting of restricted stock units | | 1,278,161 | | — | | — | | — | | — | | — |
Vesting of early exercised stock options | | 91,911 | | — | | 896 | | — | | — | | 896 |
Class A common stock withheld to satisfy employee tax withholding obligations | | (472,136) | | — | | (1,896) | | — | | — | | (1,896) |
Stock-based compensation | | — | | — | | 15,983 | | — | | — | | 15,983 |
Net unrealized loss on available-for-sale securities, net of taxes | | — | | — | | — | | (544) | | — | | (544) |
Change in translation | | — | | — | | — | | (45) | | — | | (45) |
Net loss | | — | | — | | — | | — | | (34,444) | | (34,444) |
Balances at April 30, 2023 | | 273,699,882 | | $ | 27 | | | $ | 1,531,380 | | | $ | 1,682 | | | $ | (973,740) | | | $ | 559,349 | |
Issuance of Class A common stock from the exercise of common stock options | | 1,383,413 | | — | | 3,063 | | — | | — | | 3,063 |
Issuance of Class A common stock upon vesting of restricted stock units | | 2,597,964 | | — | | — | | — | | — | | — |
Vesting of early exercised stock options | | 91,910 | | — | | 896 | | — | | — | | 896 |
Class A common stock withheld to satisfy employee tax withholding obligations | | (827,964) | | — | | (2,857) | | — | | — | | (2,857) |
Stock-based compensation | | — | | — | | 17,438 | | — | | — | | 17,438 |
Net unrealized loss on available-for-sale securities, net of taxes | | — | | — | | — | | (515) | | — | | (515) |
Change in translation | | — | | — | | — | | 169 | | — | | 169 |
Net loss | | — | | — | | — | | — | | (37,975) | | (37,975) |
Balances at July 31, 2023 | | 276,945,205 | | 27 | | 1,549,920 | | 1,336 | | (1,011,715) | | 539,568 |
Issuance of Class A common stock from the exercise of common stock options | | 226,505 | | — | | 412 | | — | | — | | 412 |
Issuance of Class A common stock upon vesting of restricted stock units | | 2,349,577 | | — | | — | | — | | — | | — |
Issuance of Class A common stock related to business combination | | 6,745,438 | | 1 | | 21,621 | | — | | — | | 21,622 |
Vesting of early exercised stock options | | 91,910 | | — | | 896 | | — | | — | | 896 |
Class A common stock withheld to satisfy employee tax withholding obligations | | (825,928) | | — | | (2,359) | | — | | — | | (2,359) |
Stock-based compensation | | — | | — | | 13,041 | | — | | — | | 13,041 |
Net unrealized gain on available-for-sale securities, net of taxes | | — | | — | | — | | 89 | | — | | 89 |
Change in translation | | — | | — | | — | | (1,667) | | — | | (1,667) |
Net loss | | — | | — | | — | | — | | (38,004) | | (38,004) |
Balances at October 31, 2023 | | 285,532,707 | | 28 | | 1,583,531 | | (242) | | (1,049,719) | | 533,598 |
See accompanying notes to unaudited condensed consolidated financial statements.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Common Stock | | Additional Paid-in Capital | | Accumulated Other Comprehensive Income (Loss) | | Accumulated Deficit | | Total Stockholders’ Equity |
| Shares | | Amount |
Balances at January 31, 2024 | | 289,275,491 | | $ | 28 | | | $ | 1,596,201 | | | $ | 1,594 | | | $ | (1,079,805) | | | $ | 518,018 | |
Issuance of Class A common stock from the exercise of common stock options | | 35,318 | | — | | 20 | | — | | — | | 20 |
Issuance of Class A common stock upon vesting of restricted stock units | | 2,334,916 | | — | | — | | — | | — | | — |
Vesting of early exercised stock options | | — | | — | | 896 | | — | | — | | 896 |
Class A common stock withheld to satisfy employee tax withholding obligations | | (908,417) | | — | | (2,015) | | — | | — | | (2,015) |
Stock-based compensation | | — | | — | | 13,745 | | — | | — | | 13,745 |
Net unrealized loss on available-for-sale securities, net of taxes | | — | | — | | — | | (512) | | — | | (512) |
Change in translation | | — | | — | | — | | (534) | | — | | (534) |
Net loss | | — | | — | | — | | — | | | (29,293) | | | (29,293) | |
Balances at April 30, 2024 | | 290,737,308 | | $ | 28 | | | $ | 1,608,847 | | | $ | 548 | | | $ | (1,109,098) | | | $ | 500,325 | |
Issuance of Class A common stock from the exercise of common stock options | | 234,443 | | — | | 280 | | — | | — | | 280 |
Issuance of Class A common stock upon vesting of restricted stock units | | 3,834,734 | | — | | — | | — | | — | | — |
Vesting of early exercised stock options | | — | | — | | 896 | | — | | — | | 896 |
Class A common stock withheld to satisfy employee tax withholding obligations | | (1,330,082) | | — | | (2,470) | | — | | — | | (2,470) |
Stock-based compensation | | — | | — | | 12,185 | | — | | — | | 12,185 |
Net unrealized gain on available-for-sale securities, net of taxes | | — | | — | | — | | 376 | | — | | 376 |
Change in translation | | — | | — | | — | | 323 | | — | | 323 |
Net loss | | — | | — | | — | | — | | | (38,668) | | | (38,668) | |
Balances at July 31, 2024 | | 293,476,403 | | $ | 28 | | | $ | 1,619,738 | | | $ | 1,247 | | | $ | (1,147,766) | | | $ | 473,247 | |
Issuance of Class A common stock from the exercise of common stock options | | 54,614 | | — | | 32 | | — | | — | | 32 |
Issuance of Class A common stock upon vesting of restricted stock units | | 3,757,861 | | — | | — | | — | | — | | — |
Issuance of Class A common stock for employee stock purchase program | | 487,557 | | — | | 924 | | — | | — | | 924 |
Vesting of early exercised stock options | | — | | — | | 896 | | — | | — | | 896 |
Class A common stock withheld to satisfy employee tax withholding obligations | | (1,343,991) | | — | | (2,843) | | — | | — | | (2,843) |
Stock-based compensation | | — | | — | | 12,330 | | — | | — | | 12,330 |
Net unrealized gain on available-for-sale securities, net of taxes | | — | | — | | — | | 48 | | — | | 48 |
Change in translation | | — | | — | | — | | 52 | | — | | 52 |
Net loss | | — | | — | | — | | — | | (20,081) | | (20,081) |
Balances at October 31, 2024 | | 296,432,444 | | 28 | | 1,631,077 | | 1,347 | | (1,167,847) | | 464,605 |
See accompanying notes to unaudited condensed consolidated financial statements.
Planet Labs PBC
Condensed Consolidated Statements of Cash Flows (Unaudited)
| | | | | | | | | | | |
| Nine Months Ended October 31, |
(in thousands) | 2024 | | 2023 |
Operating activities | | | |
Net loss | $ | (88,042) | | | $ | (110,423) | |
Adjustments to reconcile net loss to net cash used in operating activities | | | |
Depreciation and amortization | 36,365 | | | 36,033 | |
Stock-based compensation, net of capitalized cost of $1,793 and $1,851, respectively | 36,467 | | | 44,611 | |
Change in fair value of warrant liabilities | (1,126) | | | (14,004) | |
Change in fair value of contingent consideration | 3,161 | | | (923) | |
Other | (932) | | | (3,538) | |
Changes in operating assets and liabilities | | | |
Accounts receivable | 5,487 | | | (3,872) | |
Prepaid expenses and other assets | 8,499 | | | 9,483 | |
Accounts payable, accrued and other liabilities | (7,731) | | | (20,706) | |
Deferred revenue | 71 | | | 19,557 | |
Deferred hosting costs | (298) | | | (92) | |
Net cash used in operating activities | (8,079) | | | (43,874) | |
Investing activities | | | |
Purchases of property and equipment | (32,694) | | | (29,086) | |
Capitalized internal-use software | (4,145) | | | (3,266) | |
Maturities of available-for-sale securities | 57,046 | | | 142,903 | |
Sales of available-for-sale securities | 162,341 | | | 40,072 | |
Purchases of available-for-sale securities | (105,582) | | | (166,169) | |
Business acquisition, net of cash acquired | (1,068) | | | (7,542) | |
Purchases of licensed imagery intangible assets | (4,558) | | | — | |
Other | (300) | | | (944) | |
Net cash provided by (used in) investing activities | 71,040 | | | (24,032) | |
Financing activities | | | |
Proceeds from the exercise of common stock options | 332 | | | 6,770 | |
Payments for withholding taxes related to the net share settlement of equity awards | (7,328) | | | (7,112) | |
Proceeds from employee stock purchase program | 1,083 | | | — | |
Payments of contingent consideration for business acquisitions | (8,783) | | | — | |
Other | (606) | | | (15) | |
Net cash used in financing activities | (15,302) | | | (357) | |
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents | 74 | | | (65) | |
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents | 47,733 | | | (68,328) | |
Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period | 102,198 | | | 188,076 | |
Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period | $ | 149,931 | | | $ | 119,748 | |
See accompanying notes to unaudited condensed consolidated financial statements.
Planet Labs PBC
Notes to Unaudited Condensed Consolidated Financial Statements
(1)Organization
Planet Labs PBC (“Planet,” or the “Company”) was founded to design, construct, and launch constellations of satellites with the intent of providing high cadence geospatial data delivered to customers via an online platform. The Company’s mission is to use space to help life on Earth, by imaging the world every day and making global change visible, accessible, and actionable. The Company is headquartered in San Francisco, California, with operations throughout the United States (“U.S.”), Canada, Asia and Europe.
On July 7, 2021, Planet Labs Inc. (“Former Planet”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with dMY Technology Group, Inc. IV (“dMY IV”), a special purpose acquisition company (“SPAC”) incorporated in Delaware on December 15, 2020, Photon Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of dMY IV (“First Merger Sub”), and Photon Merger Sub Two, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of dMY IV (“Second Merger Sub”). Pursuant to the Merger Agreement, upon the favorable vote of dMY IV’s stockholders on December 3, 2021, on December 7, 2021, First Merger Sub merged with and into Former Planet (the “Surviving Corporation”), with Former Planet surviving the merger as a wholly owned subsidiary of dMY IV (the “First Merger”), and pursuant to Former Planet’s election immediately following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation merged with and into dMY IV, with dMY IV surviving the merger (the “Business Combination”). Following the completion of the Business Combination, dMY IV was renamed Planet Labs PBC.
Former Planet was incorporated in the state of Delaware on December 28, 2010. Former Planet was originally incorporated as Cosmogia Inc., and the name was subsequently changed to Planet Labs Inc. on June 24, 2013.
(2)Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
The accompanying condensed consolidated financial statements are unaudited; however, in the opinion of management they include all normal and recurring adjustments necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements for the periods presented. Operating results for the three and nine months ended October 31, 2024 are not necessarily indicative of the results expected for the fiscal year ending January 31, 2025 or any other future period.
The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and include the accounts of Planet Labs PBC and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year end is January 31.
Certain notes or other information that are normally required by U.S. GAAP have been condensed or omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2024 (the “2024 Form 10-K”).
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant estimates and assumptions that affect the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the useful lives of property and equipment, capitalized internal-use software and intangible assets, the Company’s incremental borrowing rate for operating leases, allowances for credit losses for available-for-sale debt securities and accounts receivable, estimates related to revenue recognition, including the assessment of performance obligations within a contract and the determination of standalone selling price (“SSP”) for each performance obligation, assumptions used to measure stock-based compensation, the fair value of private placement warrant liabilities, the fair value of assets acquired and liabilities assumed from business combinations, the fair value of contingent consideration for business combinations, the impairment of long-lived assets and goodwill, the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions, and contingencies.
These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, due to the inherent uncertainties in making estimates, actual results could differ from those estimates and such differences may be material.
Due to current geopolitical events, including the war in Ukraine and the Israel-Hamas conflict, there is ongoing uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities. These estimates and assumptions may change in the future, as new events occur, and additional information is obtained.
Segments
Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.
See Note 3, Revenue, for revenue by geographic region. See Note 6, Balance Sheet Components, for long-lived assets by geographic region.
Concentration of Credit Risk and Other Risks and Uncertainties
Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. By their nature, all such financial instruments involve risks, including the credit risk of nonperformance by counterparties. The Company’s cash, cash equivalents and short-term investments are deposited with or held by financial institutions in the U.S., Canada, Germany, the Netherlands, Slovenia, Austria, and Singapore. The Company generally does not require collateral to support the obligations of the counterparties and deposits at financial institutions may, at times, be in excess of federal or national insured limits or deposit-guarantee limits in each of the respective countries. The Company has not experienced material losses on its deposits. The maximum amount of loss at October 31, 2024 that the Company would incur if parties to cash, cash equivalents, and short-term investments failed completely to perform according to the terms of the contracts is $239.8 million.
Accounts receivable are typically unsecured and are derived from revenue earned from customers across various countries. One customer accounted for 10% of accounts receivable as of October 31, 2024. As of January 31, 2024, no customer accounted for 10% or more of accounts receivable.
For the three and nine months ended October 31, 2024, one customer accounted for 19% of revenue. For the three and nine months ended October 31, 2023, one customer accounted for 21% and 22% of revenue, respectively.
The Company’s offerings depend on continued and new approvals from the Federal Communications Commission (“FCC”), National Oceanic and Atmospheric Administration (“NOAA”), and other U.S. and international regulatory agencies for the Company to continue its operations. There can be no assurance that the Company’s operations will continue to receive the necessary approvals or that such operations will be supported by the U.S. government or other governments. If the Company was denied such approvals, if such approvals were delayed, or if the U.S. government’s or other governments’ policies change, these events may have a material adverse impact on the Company’s financial position and results of operations.
Significant Accounting Policies
The Company’s significant accounting policies are included in Note 2 of its Consolidated Financial Statements included in the 2024 Form 10-K.
Recent Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (“Topic 280”): Improvements to Reportable Segment Disclosures, which clarifies that entities with a single reportable segment are subject to both new and existing segment reporting requirements under ASC 280, and modifies certain segment disclosure requirements. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (“Topic 740”): Improvements to Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures, primarily through changes around the effective tax rate reconciliation and income taxes paid information. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.
(3)Revenue
Deferred Revenue
During the nine months ended October 31, 2024 and 2023, the Company recognized revenue of $61.6 million and $45.7 million, respectively, that had been included in deferred revenue as of January 31, 2024 and 2023, respectively.
Remaining Performance Obligations
The Company often enters into multi-year imagery licensing arrangements with its customers, whereby the Company generally invoices the amount for the first year of the contract at signing followed by subsequent annual invoices. Remaining performance obligations represent the amount of contracted future revenue that has not yet been recognized, which includes both deferred revenue and non-cancelable contracted revenue that will be invoiced and recognized in revenue in future periods. The Company’s remaining performance obligations were $145.9 million as of October 31, 2024, which consists of both deferred revenue of $77.7 million and non-cancelable contracted revenue that will be invoiced in future periods of $68.2 million. The Company expects to recognize approximately 82% of the remaining performance obligation over the next 12 months, approximately 98% of the remaining obligation over the next 24 months, and the remainder thereafter.
Remaining performance obligations do not include unexercised contract options, written orders where funding has not been appropriated and contracts which provide the customer with a right to terminate for convenience without incurring a substantive termination penalty.
Disaggregation of Revenue
The following table disaggregates revenue by major geographic region:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended October 31, | | Nine Months Ended October 31, |
(in thousands) | 2024 | | 2023 | | 2024 | | 2023 |
United States | $ | 25,294 | | | $ | 23,348 | | | $ | 83,109 | | | $ | 73,513 | |
Rest of world | 35,972 | | 32,032 | | 99,689 | | 88,331 |
Total revenue | $ | 61,266 | | | $ | 55,380 | | | $ | 182,798 | | | $ | 161,844 | |
No single country other than the U.S. accounted for more than 10% of revenue for the three and nine months ended October 31, 2024 and 2023.
Costs to Obtain and Fulfill a Contract
Commissions paid to the Company’s direct sales force are considered incremental costs of obtaining a contract with a customer. Accordingly, commissions are capitalized when incurred and amortized to sales and marketing expense over the period of benefit from the underlying contracts. The period of benefit from the underlying contract is consistent with the timing of transfer to the performance obligations to which the capitalized costs relate, and is generally consistent with the contract term.
During the three and nine months ended October 31, 2024, the Company capitalized $0.7 million and $1.4 million of deferred commission expenditures to be amortized in future periods, respectively. The Company’s amortization of deferred commission expenditures was $0.8 million and $2.1 million for the three and nine month periods ended October 31, 2024, respectively.
During the three and nine months ended October 31, 2023, the Company capitalized $0.6 million and $1.1 million of deferred commission expenditures to be amortized in future periods, respectively. The Company’s amortization of deferred commission expenditures was $0.4 million and $1.7 million for the three and nine month periods ended October 31, 2023, respectively.
As of October 31, 2024 and January 31, 2024, deferred commissions consisted of the following:
| | | | | | | | | | | |
(in thousands) | October 31, 2024 | | January 31, 2024 |
Deferred commission, current | $ | 1,884 | | | $ | 2,296 | |
Deferred commission, non-current | 1,232 | | 1,578 |
Total deferred commission | $ | 3,116 | | | $ | 3,874 | |
The current portion of deferred commissions are included in prepaid expenses and other current assets on the condensed consolidated balance sheets. The non-current portion of deferred commissions are included in other non-current assets on the condensed consolidated balance sheets.
(4)Fair Value of Financial Assets and Liabilities
Assets and liabilities recognized or disclosed at fair value in the financial statements are categorized based upon the level of judgment associated with the inputs used to measure their respective fair values.
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis for recognition or disclosure purposes as of October 31, 2024 and January 31, 2024 by level within the fair value hierarchy. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and considers factors specific to the asset or liability.
| | | | | | | | | | | | | | | | | |
| October 31, 2024 |
(in thousands) | Level 1 | | Level 2 | | Level 3 |
Assets | | | | | |
Cash equivalents: | | | | | |
Money market funds | $ | 38,503 | | | $ | — | | | $ | — | |
Restricted cash equivalents: money market funds | 9,439 | | | — | | | — | |
Short-term investments: | | | | | |
U.S. Treasury securities | 19,466 | | | $ | — | | | $ | — | |
Commercial paper | — | | | 2,943 | | | $ | — | |
Corporate bonds | — | | | 78,732 | | | $ | — | |
Certificates of deposit | — | | | 2,114 | | | $ | — | |
Total assets | $ | 67,408 | | | $ | 83,789 | | | $ | — | |
Liabilities | | | | | |
Public Warrants | $ | 1,242 | | | $ | — | | | $ | — | |
Private Placement Warrants | — | | | $ | — | | | 593 | |
Contingent consideration for acquisitions | — | | | $ | — | | | 7,282 | |
Total liabilities | $ | 1,242 | | | $ | — | | | $ | 7,875 | |
| | | | | | | | | | | | | | | | | |
| January 31, 2024 |
(in thousands) | Level 1 | | Level 2 | | Level 3 |
Assets | | | | | |
Cash equivalents: | | | | | |
Money market funds | $ | 28,722 | | | $ | — | | | $ | — | |
Restricted cash equivalents: money market funds | 17,301 | | — | | — |
Short-term investments: | | | | | |
U.S. Treasury securities | 46,211 | | — | | — |
Commercial paper | — | | 11,126 | | — |
Corporate bonds | — | | 144,340 | | — |
U.S. government agency securities | — | | 9,933 | | — |
Certificates of deposit | — | | 3,431 | | — |
Total assets | $ | 92,234 | | | $ | 168,830 | | | $ | — | |
Liabilities | | | | | |
Public Warrants | $ | 1,656 | | | $ | — | | | $ | — | |
Private Placement Warrants | — | | — | | 1,305 |
Contingent consideration for acquisitions | — | | | — | | | 12,891 | |
Total liabilities | $ | 1,656 | | | $ | — | | | $ | 14,196 | |
The fair value of cash held in banks and accrued and other current liabilities approximate the stated carrying value due to the short time to maturity and are excluded from the tables above.
Money Market Funds
The fair value of the Company’s money market funds is based on quoted active market prices for the funds and is determined using the market approach. There were no realized or unrealized gains or losses on money market funds for the three and nine months ended October 31, 2024 and 2023.
Short-term Investments
The fair value of the Company’s short-term investments classified within Level 1 are valued using quoted active market prices for the securities. The fair value of the Company’s short-term investments classified within Level 2 are valued using third-party pricing services. The pricing services utilize industry standard valuation models. Inputs utilized include market pricing based on real-time trade data for the same or similar securities and other significant inputs derived from or corroborated by observable market data.
Public and Private Placement Warrants
The Public Warrants are classified within Level 1 as they are publicly traded and had an observable market price in an active market.
The Private Placement Warrants (excluding the Private Placement Vesting Warrants) were valued based on a Black-Scholes option pricing model. Due to the market condition vesting requirements, the fair value of the Private Placement Vesting Warrants were valued using a model based on multiple stock price paths developed through the use of a Monte Carlo simulation that incorporates into the valuation the possibility that the market condition targets may not be satisfied. The Private Placement Warrants were collectively classified as a Level 3 measurement within the fair value hierarchy because these valuation models involve the use of unobservable inputs relating to the Company’s estimate of its expected stock volatility. The expected volatility input utilized for the fair value measurements of the Private Placement Warrants as of October 31, 2024 and January 31, 2024 was 70%.
Contingent Consideration for Acquisitions
The Company has recorded contingent consideration liabilities in connection with its acquisitions of Salo Sciences and Sinergise (see Note 5, Acquisitions, for the acquisition of Sinergise. See Note 6 of the Company’s Consolidated Financial Statements included in the 2024 Form 10-K). The Company measures the fair value of the contingent consideration liabilities based on significant inputs not observable in the market, which caused them to be classified as a Level 3 measurement within the fair value hierarchy.
The fair value of the contingent consideration liability for the Salo Sciences technical milestone payments is determined based on the present value of the probability-weighted payments for each of the two milestones. The significant unobservable inputs used in the fair value measurement are management’s estimate of the probability to achieve the technical milestone criteria and the discount rate. The Company determined that both of the technical milestone criteria were achieved during the nine months ended October 31, 2024.
The fair value of the contingent consideration liability for the Salo Sciences customer contract earnout payments is determined using a Monte Carlo simulation. The fair value estimate involves a simulation of future customer contract cash collections during the four-year performance period, the probability of entering into contracts with the named customers and discounting the probability-weighed earnout payments to present value. The significant unobservable inputs used in the fair value measurement are management’s estimate of obtaining the customer contracts, including probabilities, timing and contract values, and management’s estimate of the discount rate.
The fair value of the contingent consideration liability for the Sinergise customer consent escrow is determined based on the present value of the probability-weighted payments based on the likelihood of the customer consent being achieved. The significant unobservable input used in the fair value measurement is management’s estimate of the likelihood of the customer consent being achieved.
Level 3 Disclosures
The following is a roll-forward of Level 3 liabilities measured at fair value for the three and nine months ended October 31, 2024 and 2023: | | | | | | | | | | | | | | | | | | | | | | | |
(in thousands) | Private Placement Warrants | | Technical Milestone Contingent Consideration* | | Customer Contract Earnout Contingent Consideration* | | Customer Consent Escrow Contingent Consideration* |
Fair value at end of year, January 31, 2023 | $ | 9,701 | | | $ | 4,433 | | | $ | 3,597 | | | $ | — | |
Change in fair value | (3,323) | | 5 | | (428) | | — |
Fair value at April 30, 2023 | $ | 6,378 | | | $ | 4,438 | | | $ | 3,169 | | | $ | — | |
Change in fair value | (1,364) | | 211 | | (315) | | — |
Fair value at July 31, 2023 | $ | 5,014 | | | $ | 4,649 | | | $ | 2,854 | | | $ | — | |
Additions | — | | — | | — | | 5,842 |
Payments | — | | — | | (160) | | — |
Change in fair value | (3,590) | | 6 | | (478) | | 76 |
Fair value at October 31, 2023 | 1,424 | | 4,655 | | 2,216 | | 5,918 |
| | | | | | | |
Fair value at end of year, January 31, 2024 | $ | 1,305 | | | $ | 5,114 | | | $ | 1,926 | | | $ | 5,851 | |
Payments | — | | — | | (180) | | — |
Change in fair value | (771) | | (183) | | 13 | | 69 |
Fair value at April 30, 2024 | $ | 534 | | | $ | 4,931 | | | $ | 1,759 | | | $ | 5,920 | |
Payments | — | | — | | (1,090) | | — |
Change in fair value | 326 | | 579 | | 155 | | 1,291 |
Fair value at July 31, 2024 | $ | 860 | | | $ | 5,510 | | | $ | 824 | | | $ | 7,211 | |
Payments | $ | — | | | $ | — | | | $ | — | | | $ | (7,500) | |
Change in fair value | $ | (267) | | | $ | 362 | | | $ | 586 | | | $ | 289 | |
Fair value at October 31, 2024 | $ | 593 | | | $ | 5,872 | | | $ | 1,410 | | | $ | — | |
* The current portion of the contingent consideration liabilities balances of $4.4 million and $7.0 million as of October 31, 2024 and January 31, 2024, respectively, are included within accrued and other current liabilities. Changes in fair value of the contingent consideration liability for the Salo Sciences technical milestone payments are included within research and development expenses. Changes in fair value of the Salo Sciences contingent consideration liability for customer contract earnout payments are included within sales and marketing expenses. Changes in fair value of the contingent consideration liability for the Sinergise acquisition customer consent escrow payments are included within general and administrative expenses. During the three months ended October 31, 2024, evidence of the Sinergise acquisition customer consent was received and the $7.5 million in escrow was released to Sinergise.
Other
The Company measures certain non-financial assets including property and equipment, and other intangible assets at fair value on a non-recurring basis in periods after initial measurement in circumstances when the fair value of such assets are impaired below their recorded cost. As of October 31, 2024 and January 31, 2024, there were no material non-financial assets recorded at fair value.
(5)Acquisition
Sinergise
On March 26, 2023, the Company entered into an asset purchase agreement with Holding Sinergise d.o.o., a company existing under the laws of Slovenia (“Sinergise”), and its subsidiaries and certain shareholders of Sinergise, to acquire the cloud-based geo-spatial analysis products, platforms and solutions business from Sinergise. On August 4, 2023, the Company completed the acquisition.
The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. The acquisition date fair value of the consideration transferred was approximately $41.1 million, and consisted of the following:
| | | | | | | |
(in thousands) | Fair Value | | |
Cash | $ | 8,609 | | | |
Class A common stock issued | 21,622 | | | |
Liabilities for cash consideration placed in escrow account | 10,842 | | | |
Total | $ | 41,073 | | | |
The common stock issued consisted of 6,745,438 shares of the Company’s Class A common stock. The fair value of the Class A common stock was determined based on the closing market price on the date of the acquisition.
In April 2024, the Company paid $1.1 million of additional consideration in connection with the finalization of the net working capital adjustment relating to the Company’s acquisition of Sinergise. The additional amount was accounted for as a measurement period adjustment and resulted in a $1.1 million addition of goodwill during the nine months ended October 31, 2024.
Pursuant to the terms of the asset purchase agreement, the Company placed $5.0 million of cash consideration into an escrow account to secure potential indemnification obligations and any customary post-closing adjustments for working capital and indebtedness (the “Indemnity Escrow”). The amount held in the escrow account is to be released to Sinergise upon the two-year anniversary of the acquisition close date. The Company recorded a liability of $5.0 million for the Indemnity Escrow.
Pursuant to the terms of the asset purchase agreement, the Company placed an additional $7.5 million of cash consideration into an escrow account related to obtaining customer consent for a contract acquired in connection with the acquisition (the “Customer Consent Escrow”). The amount held in the escrow account is to be released to Sinergise upon the Company receiving evidence of the customer consent. If evidence of the customer consent is not received on or prior to the two year anniversary of the acquisition close date, the amount held in the Customer Consent Escrow is to be released to the Company. Additionally, the amount held in the Customer Consent Escrow is to be released to the Company if the customer contract is terminated or suspended on or prior to the two year anniversary of the acquisition close date. The Company determined that the customer consent contingency represents contingent consideration. The fair value of the contingent consideration liability as of the acquisition date was determined to be $5.8 million. Refer to Note 4 for information relating to the valuation of the Customer Consent Escrow contingent consideration.
Cash held in escrow related to the acquisition is recorded within restricted cash and cash equivalents in the Company’s condensed consolidated balance sheets.
The following table summarizes the fair value of the assets acquired and liabilities assumed as of the date of acquisition, after considering the measurement period adjustment described above:
| | | | | |
(in thousands) | |
Goodwill | $ | 24,815 | |
Identifiable intangible assets acquired | |
Developed technology | 11,811 |
Customer relationships | 2,208 |
Other | 110 |
Accounts receivable | 3,013 |
Other assets, current | 652 |
Other assets, non-current | 414 |
Total assets acquired | $ | 43,023 | |
Deferred revenue, current | (585) |
Accrued and other current liabilities | (984) |
Other liabilities, current | (213) |
Other liabilities, non-current | (167) |
Total liabilities assumed | $ | (1,949) | |
Net assets acquired | $ | 41,074 | |
The identifiable intangible assets were measured at fair value. The developed technology was valued using the royalty method under the income approach. The customer relationships were valued using the excess earnings method under the income approach. The developed technology was assigned an estimated useful life of 8 years and the customer relationships were assigned an estimated useful life of 9 years.
The excess of purchase consideration over the fair value of other assets acquired and liabilities assumed was recorded as goodwill. The goodwill primarily represents the value expected from the synergies created through the operational enhancement benefits resulting from the integration of Sinergise into the Company and the combination of Sinergise’s products and solutions with the Company’s existing products. Approximately $0.7 million of the goodwill is deductible for tax purposes.
The financial results of Sinergise are included in the condensed consolidated financial statements from the date of acquisition. Pro forma results of operations have not been presented as the effect of this acquisition was not material to the condensed consolidated financial statements.
Acquisition-related costs associated with the transaction were $0.2 million and $2.1 million for the three and nine months ended October 31, 2023, respectively. These costs were recorded within selling, general and administrative expenses.
Certain employees of Sinergise, which became employees of the Company, were paid cash transaction bonuses totaling $2.3 million in connection with the closing of the acquisition. The transaction bonuses were accounted for as a transaction separate from the business combination. Accordingly, $2.3 million of the consideration paid by the Company was allocated to the transaction bonuses and was recorded within the Company’s condensed consolidated statements of operations as summarized in the table below:
| | | | | | | |
(in thousands) | Three and Nine Months Ended October 31, 2023 | | |
Cost of revenue | $ | 267 | | | |
Research and development | 1,891 | | | |
Sales and marketing | 41 | | | |
General and administrative | 118 | | | |
Total | $ | 2,317 | | | |
(6)Balance Sheet Components
Cash and Cash Equivalents, and Restricted Cash and Cash Equivalents
Cash and cash equivalents include interest-bearing bank deposits, money market funds and other highly liquid investments with maturities of 90 days or less at the date of purchase.
The Company had restricted cash and cash equivalents balances of $11.0 million and $18.3 million as of October 31, 2024 and January 31, 2024, respectively.
The restricted cash and cash equivalents balances as of October 31, 2024 primarily consisted of $5.0 million of consideration placed in escrow in connection with the Sinergise acquisition and $4.0 million of collateral money market investments for the Company’s headquarters and other domestic office operating leases. The restricted cash and cash equivalents balances as of January 31, 2024 primarily consisted of $12.5 million of consideration placed in escrow in connection with the Sinergise acquisition and $4.0 million of collateral money market investments for the Company’s headquarters and other domestic office operating leases.
A reconciliation of the Company’s cash and cash equivalents and restricted cash and cash equivalents in the condensed consolidated balance sheets to total cash and cash equivalents, and restricted cash and cash equivalents in the condensed consolidated statements of cash flows as of October 31, 2024 and January 31, 2024 is as follows:
| | | | | | | | | | | |
| |
(in thousands) | October 31, 2024 | | January 31, 2024 |
Cash and cash equivalents | $ | 138,969 | | | $ | 83,866 | |
Restricted cash and cash equivalents, current | 6,525 | | | 8,360 |
Restricted cash and cash equivalents, non-current | 4,437 | | | 9,972 |
Total cash, cash equivalents, and restricted cash and cash equivalents | $ | 149,931 | | | $ | 102,198 | |
Short-term Investments
Short-term investments consisted of the following as of October 31, 2024 and January 31, 2024:
| | | | | | | | | | | | | | | | | | | | | | | |
| October 31, 2024 |
| | | Gross Unrealized | | |
(in thousands) | Cost or Amortized Cost | | Gains | | Losses | | Fair Value |
U.S Treasury securities | $ | 19,533 | | | $ | 2 | | | $ | (69) | | | $ | 19,466 | |
Commercial paper | 2,943 | | | — | | | — | | | 2,943 | |
Corporate bonds | 78,502 | | | 265 | | | (35) | | | 78,732 | |
Certificates of deposit | 2,114 | | | — | | | — | | | 2,114 | |
Total short-term investments | $ | 103,092 | | | $ | 267 | | | $ | (104) | | | $ | 103,255 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| January 31, 2024 |
| | | Gross Unrealized | | |
(in thousands) | Cost or Amortized Cost | | Gains | | Losses | | Fair Value |
U.S Treasury securities | $ | 46,185 | | | $ | 118 | | | $ | (92) | | | $ | 46,211 | |
Commercial paper | 11,126 | | | — | | | — | | | 11,126 | |
Corporate bonds | 144,119 | | | 376 | | | (155) | | | 144,340 | |
U.S. government agency securities | 9,928 | | | 17 | | | (13) | | | 9,932 | |
Certificates of deposit | 3,432 | | | — | | | — | | | 3,432 | |
Total short-term investments | $ | 214,790 | | | $ | 511 | | | $ | (260) | | | $ | 215,041 | |
The following table summarizes the contracted maturities of the Company’s short-term investments as of October 31, 2024 and January 31, 2024:
| | | | | | | | | | | | | | | | | | | | | | | |
| October 31, 2024 | | January 31, 2024 |
(in thousands) | Amortized Cost | | Fair Value | | Amortized Cost | | Fair Value |
Due in 1 year or less | $ | 69,910 | | | $ | 70,127 | | | $ | 148,396 | | | $ | 148,296 | |
Due in 1-2 years | 33,182 | | | 33,128 | | | 66,394 | | | 66,745 | |
| $ | 103,092 | | | $ | 103,255 | | | $ | 214,790 | | | $ | 215,041 | |
Property and Equipment, Net
Property and equipment, net consists of the following:
| | | | | | | | | | | |
| |
(in thousands) | October 31, 2024 | | January 31, 2024 |
Satellites | $ | 244,501 | | | $ | 300,203 | |
Satellites in process and not placed into service | 55,979 | | | 32,468 | |
Leasehold improvements | 17,125 | | | 17,089 | |
Ground stations and ground station equipment | 20,048 | | | 19,098 | |
Office furniture, equipment and fixtures | 10,146 | | | 8,044 | |
Computer equipment and purchased software | 9,657 | | | 9,446 | |
Total property and equipment, gross | $ | 357,456 | | | $ | 386,348 | |
Less: Accumulated depreciation | (240,536) | | | (272,919) | |
Total property and equipment, net | $ | 116,920 | | | $ | 113,429 | |
Property and equipment, net as of October 31, 2024 included $2.8 million of satellite manufacturing costs that were previously classified as prepaid expenses and other current assets as of January 31, 2024.
The Company’s long-lived assets by geographic region are as follows:
| | | | | | | | | | | |
| |
(in thousands) | October 31, 2024 | | January 31, 2024 |
United States | $ | 110,901 | | | $ | 107,070 | |
Rest of world | 6,019 | | 6,359 |
Total property and equipment, net | $ | 116,920 | | | $ | 113,429 | |
The Company concluded that satellites in service continue to be owned by the U.S. entity and accordingly are classified as U.S. assets in the table above. No single country other than the U.S. accounted for more than 10% of total property and equipment, net, as of October 31, 2024 and January 31, 2024.
Total depreciation expense for the three and nine months ended October 31, 2024 was $8.0 million and $30.3 million, respectively, of which $7.2 million and $27.9 million, respectively, was depreciation expense specific to satellites. Total depreciation expense for the three and nine months ended October 31, 2023 was $11.9 million and $31.4 million, respectively, of which $11.1 million and $29.5 million, respectively, was depreciation expense specific to satellites.
Capitalized Internal-Use Software Development Costs
Capitalized internal-use software costs, net of accumulated amortization consists of the following:
| | | | | | | | | | | |
| |
(in thousands) | October 31, 2024 | | January 31, 2024 |
Capitalized internal-use software | $ | 50,074 | | | $ | 45,010 | |
Less: Accumulated amortization | (31,815) | | | (30,037) | |
Capitalized internal-use software, net | $ | 18,259 | | | $ | 14,973 | |
Amortization expense for capitalized internal-use software for the three and nine months ended October 31, 2024 was $0.6 million and $1.8 million, respectively. Amortization expense for capitalized internal-use software for the three and nine months ended October 31, 2023 was $0.5 million and $1.4 million, respectively.
Goodwill and Intangible Assets
Goodwill and Intangible assets consists of the following:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| October 31, 2024 | | January 31, 2024 |
(in thousands) | Gross Carrying Amount | | Accumulated Amortization | | Foreign Currency Translation | | Net Carrying Amount | | Gross Carrying Amount | | Accumulated Amortization | | Foreign Currency Translation | | Net Carrying Amount |
Developed technology | $ | 30,429 | | | $ | (13,131) | | | $ | (195) | | | $ | 17,103 | | | $ | 30,429 | | | $ | (11,085) | | | $ | (220) | | | $ | 19,124 | |
Image library | 19,949 | | (13,008) | | 346 | | 7,287 | | 19,324 | | (11,852) | | 218 | | 7,690 |
Customer relationships | 7,143 | | (4,160) | | (63) | | 2,920 | | 7,143 | | (3,715) | | (42) | | 3,386 |
Trade names and other | 6,389 | | (4,499) | | 31 | | 1,921 | | 6,089 | | (3,877) | | 36 | | 2,248 |
Total intangible assets | $ | 63,910 | | | $ | (34,798) | | | $ | 119 | | | $ | 29,231 | | | $ | 62,985 | | | $ | (30,529) | | | $ | (8) | | | $ | 32,448 | |
Goodwill | $ | 135,981 | | | $ | — | | | $ | 1,430 | | | $ | 137,411 | | | $ | 134,914 | | | $ | — | | | $ | 1,342 | | | $ | 136,256 | |
Amortization expense for intangible assets for the three and nine months ended October 31, 2024 was $1.5 million and $4.3 million, respectively. Amortization